Literature DB >> 25714321

MRI kinetics with volumetric analysis in correlation with hormonal receptor subtypes and histologic grade of invasive breast cancers.

Lester Chee Hao Leong1, Eva C Gombos, Jayender Jagadeesan, Stephanie Man Chung Fook-Chong.   

Abstract

OBJECTIVE. The aim of this study was to assess whether computer-assisted detection-processed MRI kinetics data can provide further information on the biologic aggressiveness of breast tumors. MATERIALS AND METHODS. We identified 194 newly diagnosed invasive breast cancers presenting as masses on contrast-enhanced MRI by a HIPAA-compliant pathology database search. Computer-assisted detection-derived data for the mean and median peak signal intensity percentage increase, most suspicious kinetic curve patterns, and volumetric analysis of the different kinetic patterns by mean percentage tumor volume were compared against the different hormonal receptor (estrogen-receptor [ER], progesterone-receptor [PR], ERRB2 (HER2/neu), and triple-receptor expressivity) and histologic grade subgroups, which were used as indicators of tumor aggressiveness. RESULTS. The means and medians of the peak signal intensity percentage increase were higher in ER-negative, PR-negative, and triple-negative (all p ≤ 0.001), and grade 3 tumors (p = 0.011). Volumetric analysis showed higher mean percentage volume of rapid initial enhancement in biologically more aggressive ER-negative, PR-negative, and triple-negative tumors compared with ER-positive (64% vs 53.6%, p = 0.013), PR-positive (65.4% vs 52.5%, p = 0.001), and nontriple-negative tumors (65.3% vs 54.6%, p = 0.028), respectively. A higher mean percentage volume of rapid washout component was seen in ERRB2-positive tumors compared with ERRB2-negative tumors (27.5% vs 17.9%, p = 0.020). CONCLUSION. Peak signal intensity percentage increase and volume analysis of the different kinetic patterns of breast tumors showed correlation with hormonal receptor and histologic grade indicators of cancer aggressiveness. Computer-assisted detection-derived MRI kinetics data have the potential to further characterize the aggressiveness of an invasive cancer.

Entities:  

Keywords:  MRI; breast neoplasms; computer-assisted detection; kinetics; volumetric analysis

Mesh:

Substances:

Year:  2015        PMID: 25714321      PMCID: PMC4851553          DOI: 10.2214/AJR.13.11486

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  32 in total

1.  Triple-negative breast cancer: clinical features and patterns of recurrence.

Authors:  Rebecca Dent; Maureen Trudeau; Kathleen I Pritchard; Wedad M Hanna; Harriet K Kahn; Carol A Sawka; Lavina A Lickley; Ellen Rawlinson; Ping Sun; Steven A Narod
Journal:  Clin Cancer Res       Date:  2007-08-01       Impact factor: 12.531

2.  Triple-negative breast cancer: MRI features in 29 patients.

Authors:  J-H Chen; G Agrawal; B Feig; H-M Baek; P M Carpenter; R S Mehta; O Nalcioglu; M-Y Su
Journal:  Ann Oncol       Date:  2007-11-20       Impact factor: 32.976

3.  In situ and minimally invasive breast cancer: morphologic and kinetic features on contrast-enhanced MR imaging.

Authors:  P Viehweg; D Lampe; J Buchmann; S H Heywang-Köbrunner
Journal:  MAGMA       Date:  2000-12       Impact factor: 2.310

4.  [Magnetic resonance imaging of breast cancer: correlation between contrast enhancement and tumor angiogenesis].

Authors:  A Furuta; T Ishibashi; S Takahashi; S Yamada; N Ohuchi; G Amano; K Goto; M Watanabe
Journal:  Nihon Igaku Hoshasen Gakkai Zasshi       Date:  1999-10

5.  Breast masses with peripheral rim enhancement on dynamic contrast-enhanced MR images: correlation of MR findings with histologic features and expression of growth factors.

Authors:  R Matsubayashi; Y Matsuo; G Edakuni; T Satoh; O Tokunaga; S Kudo
Journal:  Radiology       Date:  2000-12       Impact factor: 11.105

Review 6.  Angiogenesis in cancer and other diseases.

Authors:  P Carmeliet; R K Jain
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

7.  Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor.

Authors:  Jenny Chang; Gary M Clark; D Craig Allred; Syed Mohsin; Gary Chamness; Richard M Elledge
Journal:  Cancer       Date:  2003-02-01       Impact factor: 6.860

8.  A wide variety of dynamic contrast-enhanced MR appearances of breast cancer: pathologic correlation study.

Authors:  Masayuki Onishi; Akira Furukawa; Masashi Takahashi; Kiyoshi Murata
Journal:  Eur J Radiol       Date:  2007-08-01       Impact factor: 3.528

Review 9.  Application of magnetic resonance imaging to angiogenesis in breast cancer.

Authors:  M O Leach
Journal:  Breast Cancer Res       Date:  2001       Impact factor: 6.466

10.  Correlation between high resolution dynamic MR features and prognostic factors in breast cancer.

Authors:  Shin Ho Lee; Nariya Cho; Seung Ja Kim; Joo Hee Cha; Kyung Soo Cho; Eun Sook Ko; Woo Kyung Moon
Journal:  Korean J Radiol       Date:  2008 Jan-Feb       Impact factor: 3.500

View more
  10 in total

1.  Utilization of magnetic resonance imaging in breast cancer screening.

Authors:  D Lin; L Moy; D Axelrod; J Smith
Journal:  Curr Oncol       Date:  2015-10       Impact factor: 3.677

2.  Differentiation of triple-negative breast cancer from other subtypes through whole-tumor histogram analysis on multiparametric MR imaging.

Authors:  Tianwen Xie; Qiufeng Zhao; Caixia Fu; Qianming Bai; Xiaoyan Zhou; Lihua Li; Robert Grimm; Li Liu; Yajia Gu; Weijun Peng
Journal:  Eur Radiol       Date:  2018-11-06       Impact factor: 5.315

3.  Feasibility analysis of early temporal kinetics as a surrogate marker for breast tumor type, grade, and aggressiveness.

Authors:  Laura Heacock; Alana A Lewin; Yiming Gao; James S Babb; Samantha L Heller; Amy N Melsaether; Neeti Bagadiya; Sungheon G Kim; Linda Moy
Journal:  J Magn Reson Imaging       Date:  2017-11-27       Impact factor: 4.813

4.  Characterizing and eliminating errors in enhancement and subtraction artifacts in dynamic contrast-enhanced breast MRI: Chemical shift artifact of the third kind.

Authors:  Jamal J Derakhshan; Elizabeth S McDonald; Evan S Siegelman; Mitchell D Schnall; Felix W Wehrli
Journal:  Magn Reson Med       Date:  2017-08-24       Impact factor: 4.668

5.  Comparison of conventional DCE-MRI and a novel golden-angle radial multicoil compressed sensing method for the evaluation of breast lesion conspicuity.

Authors:  Laura Heacock; Yiming Gao; Samantha L Heller; Amy N Melsaether; James S Babb; Tobias K Block; Ricardo Otazo; Sungheon G Kim; Linda Moy
Journal:  J Magn Reson Imaging       Date:  2016-11-17       Impact factor: 4.813

6.  Estimation of the capillary level input function for dynamic contrast-enhanced MRI of the breast using a deep learning approach.

Authors:  Jonghyun Bae; Zhengnan Huang; Florian Knoll; Krzysztof Geras; Terlika Pandit Sood; Li Feng; Laura Heacock; Linda Moy; Sungheon Gene Kim
Journal:  Magn Reson Med       Date:  2022-01-09       Impact factor: 4.668

Review 7.  Breast Cancer Subtypes and Quantitative Magnetic Resonance Imaging: A Systemic Review.

Authors:  Toshiki Kazama; Taro Takahara; Jun Hashimoto
Journal:  Life (Basel)       Date:  2022-03-28

8.  Characterization of breast cancer subtypes based on quantitative assessment of intratumoral heterogeneity using dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging.

Authors:  Jin Joo Kim; Jin You Kim; Hie Bum Suh; Lee Hwangbo; Nam Kyung Lee; Suk Kim; Ji Won Lee; Ki Seok Choo; Kyung Jin Nam; Taewoo Kang; Heeseung Park
Journal:  Eur Radiol       Date:  2021-08-04       Impact factor: 5.315

9.  Preoperative dynamic breast magnetic resonance imaging kinetic features using computer-aided diagnosis: Association with survival outcome and tumor aggressiveness in patients with invasive breast cancer.

Authors:  Sang Yu Nam; Eun Sook Ko; Yaeji Lim; Boo-Kyung Han; Eun Young Ko; Ji Soo Choi; Jeong Eon Lee
Journal:  PLoS One       Date:  2018-04-12       Impact factor: 3.240

10.  Automated volumetric radiomic analysis of breast cancer vascularization improves survival prediction in primary breast cancer.

Authors:  Matthias Dietzel; Rüdiger Schulz-Wendtland; Stephan Ellmann; Ramy Zoubi; Evelyn Wenkel; Matthias Hammon; Paola Clauser; Michael Uder; Ingo B Runnebaum; Pascal A T Baltzer
Journal:  Sci Rep       Date:  2020-02-28       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.